Search

Search results

Current filters: HIV drugs, HIV, Treatment, English, Dolutegravir (Tivicay), Research summary

27 search results

Dolutegravir and TAF or TDF—safety issues and weight gain

From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage

Decreasing the risk of neural tube defects with dolutegravir

From TreatmentUpdate 233
2019, CATIE
Research summary - Webpage

Higher levels of dolutegravir in older people not linked to side effects

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Large French study examines neuropsychiatric side effects with integrase inhibitors

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Can high-dose dolutegravir be a rescue therapy?

From TreatmentUpdate 230
2019, CATIE
Research summary - Webpage

Italian study explores dual drug regimens as maintenance treatment

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage

Dolutegravir + 3TC for the initial treatment of HIV

From TreatmentUpdate 229
2018, CATIE
Research summary - Webpage

Agencies issue caution about use of dolutegravir by pregnant HIV-positive women

2018, CATIE
Research summary - Webpage

Winnipeg doctors use dolutegravir and darunavir for simplifying treatment

2018, CATIE
Research summary - Webpage

Preliminary results of dolutegravir + 3TC for initial therapy of HIV

From TreatmentUpdate 224
2018, CATIE
Research summary - Webpage